Key facts
- Notable investors include National Institutes of Health, BioGenerator Ventures, Anthropy Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Axioforce
- ·The full record, as it builds
Funding rounds
No funding rounds for Axioforce are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axioforce
Developer of a three-dimensional sensing shoe insole designed to calculate automated gait insights. The company's product is based on finely tuned magnetic silicone composite constructs that offer design flexibility, enabling clinicians to detect gait disorders and declining functional mobility, helping prevent further loss of independence.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2022
- Employees
- 10
- Website
- axioforce.com/
- Ownership
- Privately Held (backing)
Axioforce doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axioforce shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axioforce in its N-PORT filings yet. We sweep new filings monthly.